Adagene Inc - ADR (ADAG) Stock Price

1.84 ▼ -0.07 (-3.66%)
Open: 1.905 Vol: 65.23K Day's range: 1.75 - 1.905 Oct 14, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ADAG Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.88▼ 1.88▼ 1.88▼ 1.92▼ 1.96▼
MA10 1.89▼ 1.89▼ 1.89▼ 1.95▼ 2.04▼
MA20 1.91▼ 1.91▼ 1.91▼ 1.99▼ 1.99▼
MA50 1.93▼ 1.96▼ 1.98▼ 2.09▼ 1.92▼
MA100 1.98▼ 2.13▼ 2.16▼ 2.00▼ 2.28▼
MA200 2.18▼ 2.13▼ 2.08▼ 1.89▼ 2.33▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.007▼ -0.005▼ -0.004▼ -0.012▼ -0.013▼
RSI 26.129▼ 30.413▼ 29.978▼ 35.664▼ 46.517▼
STOCH 56.263     21.997     18.968▼ 43.201     22.692    
WILL %R -100.000▼ -100.000▼ -100.000▼ -72.727     -84.615▼
CCI -432.309▼ -369.926▼ -394.868▼ -263.588▼ -90.334    
Latest Filters Detected On ADAG
MA $ADAG Price Crossed Below MA(200) Set Alert
▼ BREAK $ADAG Price Breaks 30 Days Low Set Alert
▼ BREAK $ADAG Price Breaks 20 Days Low Set Alert
▼ BREAK $ADAG Price Breaks 10 Days Low Set Alert
Adagene Inc - ADR News
Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate
Tuesday, September 16, 2025 05:00 AM
SAN DIEGO and SUZHOU, China, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) today announced an amendment to the 2021 collaboration and license agreement with Exelixis.
LUCID CAPITAL MARKETS Initiates Coverage of Adagene Inc. - Depositary Receipt (ADAG) with Buy Recommendation
Friday, September 12, 2025 05:00 PM
Fintel reports that on September 18, 2025, LUCID CAPITAL MARKETS initiated coverage of Adagene Inc. - Depositary Receipt (NasdaqGM:ADAG) with a Buy recommendation. As of September 13, 2025, the ...
Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
Friday, September 05, 2025 06:54 AM
“Microsatellite stable (MSS) colorectal cancer (CRC) remains one of the cold tumors where effective immunotherapy still remains elusive and I believe anti-CTLA-4 therapy should be part of the solution ...
ADAG historical stock data
date open high low close volume
14/10/25 1.905 1.905 1.75 1.84 65,229
13/10/25 1.98 1.99 1.88 1.91 26,057
10/10/25 1.98 2.00 1.85 1.95 66,637
09/10/25 1.92 1.989 1.90 1.95 64,069
08/10/25 1.95 2.065 1.90 1.955 648,881
07/10/25 1.97 1.99 1.88 1.99 56,394
06/10/25 1.99 2.025 1.95 1.99 40,521
03/10/25 1.9352 2.05 1.9138 1.98 38,816
02/10/25 2.06 2.06 1.85 1.94 114,807
01/10/25 1.99 2.03 1.9666 2.00 27,204
Quote Details
52wk Low:1.325
52wk High:3.16
Vol:65.23K
Avg Vol(3m):1.7M
1Y Chng:-38.87%
1M Chng:-15.60%
Add to Watch List
More Information
Index US Composite
Market Cap. 90.02M